US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist
  • 1.110
  • +0.090+8.82%
Close Dec 20 16:00 ET
  • 1.160
  • +0.050+4.50%
Post 20:01 ET
44.65MMarket Cap-0.74P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Barinthus Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q314.969M / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q314.969M / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Barinthus Biotherapeutics Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 6 08:12 ET

  • 8-K: Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

    Nov 6 08:07 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 8 08:14 ET

  • 8-K: Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results

    Aug 8 08:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data